# LifeMine Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lifemine-therapeutics

- Industry: Biotechnology
- Headquarters: Watertown, US
- Website: www.lifeminetx.com
- Total disclosed funding: $521M
- Latest round: Series E (Jul 31, 2026)
- Investors on record: 19

## About

Based in the US, LifeMine Technologies, Inc. operates as a drug discovery company that develops small-molecule drugs for tumors and immune modulation.Founded in 2017, and based in Massachusetts, US by Gregory Verdine, Richard Klausner, and WeiQing Zhou, LifeMine Technologies, Inc. is a biopharmaceutical company that engages in the R&D of small molecule drugs. It has an additional two offices in Gloucester Harbor and Basel. In July 2026, LifeMine Therapeutics, Inc. raised USD 188 million in series E funding led by new investor Milky Way Ventures, with participation from other new investors Bezos Expeditions, Gates Foundation Trust, and RA Capital Management. Returning investors ARCH Venture Partners, GlaxoSmithKline, GV, Invus Financial Advisors, LoLa Capital Partners, and other unspecified investors also participated in the round.LifeMine Technologies, Inc. engages in the R&D of new drugs for tumors and immune modulation. It has established a fungal genome repository that mines fungal biodiversity to develop novel therapeutics. It also established a drugs R&D platform, Avatar-Rx platform, which integrates high-throughput microbiology, data science and machine learning, genome engineering, and automation technologies to search the fungal biosphere for target genetically-encoded small molecules (GEMs ).

## Funding rounds

- Series E, Jul 31, 2026, $151M — ARCH Venture Partners, Gates Foundation Trust, GlaxoSmithKline, GV, RA Capital Management, Bezos Expeditions, Invus Financial Advisors, Milky Way Ventures, LoLa Capital Partners
- Series D, Dec 31, 2025, $75M — GlaxoSmithKline, GV, LoLa Capital Partners
- Series C, Mar 23, 2022, $175M — ARCH Venture Partners, Invus [DUP], Fidelity Investments, GlaxoSmithKline, GV, Blue Pool Capital, 3W Partners, MRL Ventures Fund
- Series B, Jan 7, 2021, $50M — ARCH Venture Partners, Merck Global Health Innovation Fund, GV, Foresite Capital, Blue Pool Capital, 6 Dimensions Capital, Milky Way Ventures
- Series A, Mar 29, 2019, $45M — ARCH Venture Partners, Alexandria Venture Investments, Merck Global Health Innovation Fund, GV, Boyu Capital, Foresite Capital, Blue Pool Capital, 6 Dimensions Capital
- Series A, Sep 18, 2017, $25M — ARCH Venture Partners, Alexandria Venture Investments, Merck Global Health Innovation Fund, GV, Boyu Capital, Foresite Capital, Blue Pool Capital, 6 Dimensions Capital

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A, Series B, Series C, Series E
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Merck Global Health Innovation Fund (https://capitalatlas.ai/funds/merck-global-health-innovation-fund) — Series A, Series B
- GV (https://capitalatlas.ai/funds/gv) — Series A, Series B, Series C, Series D, Series E
- Boyu Capital (https://capitalatlas.ai/funds/boyu-capital) — Series A
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series A, Series B
- Blue Pool Capital (https://capitalatlas.ai/funds/blue-pool-capital) — Series A, Series B, Series C
- 6 Dimensions Capital (https://capitalatlas.ai/funds/6-dimensions-capital) — Series A, Series B
- Milky Way Ventures (https://capitalatlas.ai/funds/milky-way-ventures) — Series B, Series E
- Invus [DUP] — Series C
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series C
- GlaxoSmithKline — Series C, Series D, Series E
- 3W Partners (https://capitalatlas.ai/funds/3w-partners) — Series C
- MRL Ventures Fund (https://capitalatlas.ai/funds/mrl-ventures-fund) — Series C
- LoLa Capital Partners (https://capitalatlas.ai/funds/lola-capital-partners) — Series D, Series E
- Gates Foundation Trust — Series E
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series E
- Bezos Expeditions — Series E
- Invus Financial Advisors (https://capitalatlas.ai/funds/invus-financial-advisors) — Series E